Major Gift Will Support an Innovative Brain Research Collaboration
The Swiss-based NOMIS Foundation is making a large five-year award for research into what makes the human brain unique. The research will be a collaboration between the laboratories of James P. Noonan, PhD, associate professor of genetics and of neuroscience at Yale School of Medicine, and Franck Polleux, PhD, professor of neuroscience at Columbia University and a member of that school’s Zuckerman Institute. Their combined mission is to understand the brain and mind.
Gift by Rothberg Family Reinforces Yale Coronavirus Response
“Our doctors, nurses, and first responders, and all of our health care workers are saving the lives of people we love. We each need to do everything we can to keep them safe and let them know that we are there for them,” says Jonathan Rothberg.
Yale School of Medicine Maintains its High National Ranking in Federal Research Funding
The 2019 total, $451,476,354, continues the school’s position in the top ten among U.S. medical schools that it has maintained each year since 2001. YSM ranked first in funding for psychiatry and dermatology; third for public health/preventive medicine and emergency medicine; fifth for radiology; sixth for neurology and ob-gyn; seventh for neurosurgery; and ninth for biochemistry, genetics, and internal medicine.
YCCI Scholar Awards: Letters of Intent Due on Jan. 13
We are pleased to announce a request for applications for YCCI Scholar Awards, which provide salary and/or research funds to a select number of junior faculty members who are strongly committed to careers in clinical research, community-based research or translational research.
Yale Investigators Receive NIH HEAL Grants to Study Solutions to the Opioid Crisis
Yale researchers representing a range of disciplines have been awarded grants through the National Institutes of Health (NIH) Helping to End Addiction Long-term Initiative (HEAL). This national effort provides $945 million in total funding to support a variety of research projects that tackle the opioid addiction and overdose crisis.
Department of Neurology Receives Major Grant to Evaluate Blood Thinners and Stroke Prevention
Yale School of Medicine has received a 5-year, $20 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to administer a Phase III trial measuring the effectiveness of using a blood thinner to prevent new strokes in patients who suffered brain hemorrhages and have atrial fibrillation, or irregular heartbeat.
Yale Cancer Center Scientists Receive Grant to Advance Lung Cancer Research
Katerina Politi, PhD and Don Nguyen, PhD, members of the Signal Transduction Research Program at Yale Cancer Center (YCC), have received a 5-year, nearly $4 million National Cancer Institute (NCI) grant to support Lung Cancer research.
Krumholz, Spatz receive funding to develop new 24/7 blood pressure monitor
The National Institute of Biomedical Imaging and Bioengineering has awarded a $1.2 million, four-year grant to investigators at Texas A&M University and Yale University for the development of a wrist-worn, cuffless blood pressure monitoring system.
CERSI Obtains FDA Grant Renewal
Joseph S. Ross, MD, MHS, associate professor of medicine (general medicine) and public health (health policy and management) was awarded a U.S. Food & Drug Administration (FDA) grant renewal up to $20M for work on the Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI). The grant was recently renewed for years three through seven.
Yale center dedicated to research on older adults receives renewed funding
For the fifth consecutive time, the Yale Claude D. Pepper Older Americans Independence Center (OAIC) has been renewed for funding from the National Institute on Aging (NIA). The Center is one of only two such programs nationwide to receive continuous NIA support since it was first funded in 1992, marking more than 25 years of excellence in geriatrics and aging research under the leadership of Geriatrics Section Chief Dr. Mary Tinetti, Dr. Thomas Gill, and Dr. Terri Fried.
Initial Deadline Extended to June 30 for Fund to Retain Clinical Scientists at Yale
Applicants must be full-time Yale faculty at the level of Assistant Professor, Instructor or Associate Research Scientist, and have an MD or DO degree, a current medical license, and some clinical responsibilities.
Blavatnik Family Foundation gives $15 million to expand fund for innovation in the life sciences at Yale University
Yale University has received a $15 million grant from the Blavatnik Family Foundation, headed by American industrialist and philanthropist Len Blavatnik, to expand the Blavatnik Fund for Innovation at Yale. First established in 2016 with a grant of $10 million, the Blavatnik Fund advances entrepreneurship in the life sciences at Yale and expedites the development, application, and commercialization of breakthrough research. The new grant will build on the fund’s early successes in bolstering translational research and propelling the work of investigators toward the marketplace.
Emergency physicians receive grant to advance treatment for opioid users
“Opioid use disorder, dependence on prescription opioids and heroin, is a major public health problem taking a devastating toll on Americans, their families, and their communities. Three million Americans have or have had opioid use disorder,” wrote Dr. Ted Melnick and Dr. Gail D’Onofrio in their proposal to the National Institute on Drug Abuse (NIDA).
YCCI Beginning a Second Decade of Support
Although it is hard to believe, the Yale Center for Clinical Investigation (YCCI) is now in its second decade providing training resources and support for Yale’s clinical and translational investigators. With the second renewal of the Clinical and Translational Science Award (CTSA), YCCI is well poised to continue supporting innovative science to improve the health of patients everywhere.